{
    "medicine_id": "2d54ea35d097020a21ff13d716cd6b1bb0eded2f",
    "platform_id": "DB09013",
    "metadata": {
        "name": "Igatan F 150 MG 3ML Injection solution",
        "composition": "150 MG 3ML Befunolol",
        "clinical_particulars": {
            "therapeutic_indications": "Used in the management of open angle glaucoma PMID 12480285",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00763",
                        "description": "The excretion of Befunolol can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The serum concentration of Befunolol can be increased when it is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Befunolol can be decreased when combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "Lasmiditan may increase the bradycardic activities of Befunolol"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Befunolol can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The risk or severity of adverse effects can be increased when Verapamil is combined with Befunolol"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Befunolol can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Befunolol may increase the sympathomimetic activities of Formoterol"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Befunolol"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Befunolol can be increased when it is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Befunolol can be increased when it is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The serum concentration of the active metabolites of Befunolol can be increased when Befunolol is used in combination with Octreotide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}